To access this element change to forms mode OFF
Grant Award View - GA30136
Dynamin modulators for reversing immunotherapy resistance in head and...
GA ID:
GA30136
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$1,493,752.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Dynamin modulators for reversing immunotherapy resistance in head and neck cancer
Purpose:
This team has spent over 20 years developing specific dynamin inhibitors, and have now identified a single novel class of dynamin inhibitors that will be rapidly developed as the primary chemical series for combination therapy with cetuximab. In this project, we propose to advance our many years of work to develop this series of dynamin inhibitors to a pre-clinical lead candidate suitable for clinical development.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162515
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, QLD
Postcode:
Multiple
Country:
AUSTRALIA